What's new

Human medicines European public assessment report (EPAR): Emcitate, tiratricol, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Emcitate, tiratricol, Date of authorisation: 12/02/2025, Status: Authorised

Mar 11, 2025 - 11:27
 0
Human medicines European public assessment report (EPAR): Emcitate, tiratricol, Date of authorisation: 12/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Emcitate, tiratricol, Date of authorisation: 12/02/2025, Status: Authorised
Read More

Tags:

Previous Article

Automation could save dealer groups £1 million a year, says Autofinity

Next Article

Cancer Medicines Forum: December 2024, Online, European Medicines Agency, Amster...

Related Posts

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius Kabi, pemetrexed, Date of authorisation: 22/07/2016, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Human medicines European public assessment report (EPAR): Pedea, ibuprofen, Date of authorisation: 28/07/2004, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 7, 2025  0

Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation: 26/04/2019, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0